Trial intelligence / Profile preview

Food Effect on Mebendazole Bioavailability

NCT02051738Phase 1Completed

Sponsor
Janssen Pharmaceutical
Start
Feb 2014
Primary completion
Apr 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of mebendazole in helminthiasis (2 arms), sponsored by Janssen Pharmaceutical. Primary endpoint: Concentration of mebendazole in blood and urine. Started Feb 2014; status: completed.

02

Drugs

mebendazole
03

Conditions

helminthiasis

Beyond the preview

Go deeper on NCT02051738.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02051738.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call